Gloria Barnett-Duncan
Psychiatric/Mental Health · Hyannis, MANPI 1346627064
Payments from drug & device makers
Across 125 payments — averaging $25.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$759
- Otsuka America Pharmaceutical, Inc.$674
- AbbVie$286
- Alkermes, Inc.$245
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$232
- Vanda Pharmaceuticals Inc.$183
- plus $824 from 11 others
What the payments were for
- Food & beverage$3,204100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 29 | $759 |
| Otsuka America Pharmaceutical, Inc. | 23 | $674 |
| AbbVie | 11 | $286 |
| Alkermes, Inc. | 12 | $245 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $232 |
| Vanda Pharmaceuticals Inc. | 7 | $183 |
| Axsome Therapeutics, Inc. | 3 | $179 |
| Teva Pharmaceuticals USA, Inc. | 9 | $173 |
| E.r. Squibb & Sons, L.L.C. | 4 | $106 |
| Lundbeck LLC | 5 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Neurocrine Biosciences, Inc. | 2 | $54 |
| Sunovion Pharmaceuticals Inc. | 3 | $52 |
| Corium, LLC | 2 | $40 |
| Luye Pharma (USA) Ltd. | 2 | $37 |
| Sage Therapeutics, LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$249
- INVEGA SUSTENNA$129
- Auvelity$114
How this compares
$3,204 in reported general payments places this provider in the 90th percentile of 1,284 psychiatric/mental health providers in Massachusetts.
See all psychiatric/mental health providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olanzapine | 190 | $3,311 |
| Divalproex Sodium | 87 | $2,395 |
| Methylphenidate ErMethylphenidate Hcl | 12 | $2,209 |
| Bupropion XlBupropion Hcl | 67 | $2,093 |
| Escitalopram Oxalate | 70 | $1,673 |
| Buspirone Hcl | 100 | $1,306 |
| Trazodone Hcl | 147 | $1,163 |
| Aripiprazole | 80 | $1,016 |
| Mirtazapine | 50 | $919 |
| Sertraline Hcl | 138 | $848 |
| Lamotrigine | 89 | $848 |
| Bupropion Hcl SrBupropion Hcl | 43 | $754 |
| Fluoxetine Hcl | 128 | $744 |
| Quetiapine Fumarate | 120 | $683 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 38 | $682 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Hyannis
- Brianne LienkampMarion$121K
- Ashley BakerQuincy$54K
- Brian BanksPembroke$47K
- Anne-Margaret BotelhoMattapoisett$46K
- Matthew PeculisWalpole$41K
- Sherrie UrenaWorcester$21K
- Irina DauphineeHanover$18K
- Schree PettigrewNew Bedford$18K
- Sherryl RosenLynn$16K
- Kevin NardoneWorcester$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.